Aclaris Therapeutics (ACRS) to Acquire Vixen Pharma and Rights to Intellectual Property for Potential Treatment for Hair Loss

March 28, 2016 4:10 PM

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical stage specialty pharmaceutical company, today announced that it has entered into an agreement ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found